Skip to content
zameds

Zoledronate trisodium (Zometa)

Zoledronate trisodium

Novartis South Africa (Pty) Ltd

Every registration of this product has been cancelled.

Registration

Applicant
Novartis South Africa (Pty) Ltd
Certificate holder
Novartis South Africa (Pty) Ltd
Registrations
1

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Zometa 4mg

EACH VIAL CONTAINS: ZOLEDRONATE TRISODIUM 4,0 mg

4 mgConcentrate for solution for infusion38008638/34/0086Approved 16 August 2021CancelledNot determinedPIPIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

No structure available

This product's active ingredient could not be matched to a single known compound.

SAHPRA documents

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles